Literature DB >> 3293848

Accelerated development of immunity following transplantation of maternal marrow stem cells into infants with severe combined immunodeficiency and transplacentally acquired lymphoid chimerism.

M J Barrett1, R H Buckley, S E Schiff, P C Kidd, F E Ward.   

Abstract

Transplacentally acquired lymphoid chimerism was detected in two infants with severe combined immunodeficiency (SCID) by two-colour cytofluorographic studies. These cells had no demonstrable function in studies in vitro. Following T cell-depleted maternal bone marrow stem cell transplantation, evidence of T cell function was detected 20 and 50 days later, and transient B cell function was detected 50 days later. These immune functions appeared much sooner than the 90-120 days usually required for T cell function and the 2-2.5 years for B cell function to develop after haplo-identical stem cell transplants into SCID infants without transplacental engraftment. The presence of maternal lymphoid chimerism did not interfere with haplo-identical marrow cell engraftment, even though no pre-transplant immunosuppression was given. This observation suggests that the transplanted maternal marrow stem cell in some way conferred reactivity on the engrafted but apparently non-functional mature T cells that had entered the fetal circulation transplacentally.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3293848      PMCID: PMC1541504     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Graft-versus-host reaction (GVHR). A case report suggesting GVHR occurred as a result of maternofetal cell transfer.

Authors:  T M Grogan; D D Broughton; W F Doyle
Journal:  Arch Pathol       Date:  1975-06

2.  Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy.

Authors:  R H Buckley; S C Dees; W M O'Fallon
Journal:  Pediatrics       Date:  1968-03       Impact factor: 7.124

3.  Chimerism detected by HL-A typing.

Authors:  R J O'Reilly; J H Patterson; F H Bach; M L Bach; R Hong; F Kissmeyer-Nielsen; A J Therkelsen
Journal:  Transplantation       Date:  1973-05       Impact factor: 4.939

4.  Studies of human bone marrow treated with soybean lectin and sheep erythrocytes: stepwise analysis of cell morphology, phenotype and function.

Authors:  S E Schiff; J Kurtzberg; R H Buckley
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

5.  Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency.

Authors:  M S Pollack; D Kirkpatrick; N Kapoor; B Dupont; R J O'Reilly
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

6.  Nature of reconstitution with histoincompatible maternal marrow in a case of severe combined immunodeficiency with graft-versus-host disease following maternofetal transfusion.

Authors:  D Niethammer; S F Goldmann; H D Flad; U Bienzle; U Dieterle; R J Haas; B Heymer; W Meigel; B H Belohradsky; E Kleihauer
Journal:  Clin Immunol Immunopathol       Date:  1981-03

7.  Membrane receptors and in vitro responsiveness of lymphocytes in human immunodeficiency.

Authors:  R I Schiff; R H Buckley; R B Gilbertsen; R S Metzgar
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

8.  XX-XY lymphoid chimaerism in congenital immunological deficiency syndrome with thymic alymphoplasia.

Authors:  J Kadowaki; R I Thompson; W W Zuelzer; P V Woolley; A J Brough; D Gruber
Journal:  Lancet       Date:  1965-12-04       Impact factor: 79.321

9.  Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation.

Authors:  M M Bortin; A A Rimm
Journal:  JAMA       Date:  1977-08-15       Impact factor: 56.272

10.  Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells.

Authors:  Y Reisner; N Kapoor; D Kirkpatrick; M S Pollack; S Cunningham-Rundles; B Dupont; M Z Hodes; R A Good; R J O'Reilly
Journal:  Blood       Date:  1983-02       Impact factor: 22.113

View more
  7 in total

1.  Transplantation tolerance to a single noninherited MHC class I maternal alloantigen studied in a TCR-transgenic mouse model.

Authors:  Yoshinobu Akiyama; Stéphane M Caucheteux; Cécile Vernochet; Yoshiko Iwamoto; Katsunori Tanaka; Colette Kanellopoulos-Langevin; Gilles Benichou
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

Review 2.  Hematopoietic stem cell transplantation for primary immunodeficiencies.

Authors:  Elizabeth Kang; Andrew Gennery
Journal:  Hematol Oncol Clin North Am       Date:  2014-09-16       Impact factor: 3.722

Review 3.  Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.

Authors:  Rebecca H Buckley
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

4.  Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency.

Authors:  Anne Marie Comeau; Jaime E Hale; Sung-Yun Pai; Francisco A Bonilla; Luigi D Notarangelo; Mark S Pasternack; H Cody Meissner; Ellen Rae Cooper; Alfred DeMaria; Inderneel Sahai; Roger B Eaton
Journal:  J Inherit Metab Dis       Date:  2010-05-20       Impact factor: 4.982

5.  Development of multiple monoclonal serum immunoglobulins (multiclonal gammopathy) following both HLA-identical unfractionated and T cell-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency.

Authors:  E F Kent; J Crawford; H J Cohen; R H Buckley
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

6.  X-linked severe combined immunodeficiency. Diagnosis in males with sporadic severe combined immunodeficiency and clarification of clinical findings.

Authors:  M E Conley; R H Buckley; R Hong; C Guerra-Hanson; C M Roifman; J A Brochstein; S Pahwa; J M Puck
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

7.  Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency.

Authors:  A E Pepper; R H Buckley; T N Small; J M Puck
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.